A fatal primary gastric melanoma treated by a double immunotherapy with ipilimumab/nivolumab: description of a case report.

Date publication

octobre 2022

Journal

Journal of gastrointestinal oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LONGO Raffaele

Tous les auteurs :
Longo R, Colin S, Streiff C, Wendel C, Bonhomme A, Sava C, Campitiello M, Plastino F, Egea J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36388646

Résumé

Primary gastric melanoma (GM) is a very uncommon tumor with a poor prognosis. Until now, only a few cases have been reported in the literature.

Mots clés

Melanoma, case report, gastric cancer, immunotherapy

Référence

J Gastrointest Oncol. 2022 10;13(5):2615-2619